Life Insurance Corporation of India (LIC) has increased its stake in Granules India Ltd, a leading pharmaceutical company, to 5.02%. LIC purchased an additional 17.83 lakh shares between January 1 and March 3, 2025, raising its holding from 4.26% as of December 2024.
Following this investment, Granules India’s stock saw an uptick, trading at ₹473.55 on the BSE by 2:50 pm, reflecting a 2.6% increase from the previous close.
This move underscores the growing institutional confidence in Granules India, which manufactures Active Pharmaceutical Ingredients (APIs), Formulation Intermediates (PFIs), and Finished Dosages (FDs) for global markets. The pharma company caters to various international markets, reinforcing its position as a key player in the pharmaceutical industry.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
